Technical Analysis for AURA - Aura Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.97% | |
| MACD Bearish Signal Line Cross | Bearish | 0.97% | |
| Bollinger Band Squeeze | Range Contraction | 0.97% | |
| Gapped Down | Weakness | 0.97% | |
| 50 DMA Resistance | Bearish | -3.07% | |
| 20 DMA Support | Bullish | -3.07% | |
| Bollinger Band Squeeze | Range Contraction | -3.07% | |
| BB Squeeze + Upper Band Touch | Range Contraction | -3.07% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 1 day ago |
| Down 2 % | 1 day ago |
| Down 1% | 1 day ago |
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.5 |
| 52 Week Low | 5.9906 |
| Average Volume | 196,625 |
| 200-Day Moving Average | 8.57 |
| 50-Day Moving Average | 7.54 |
| 20-Day Moving Average | 7.40 |
| 10-Day Moving Average | 7.41 |
| Average True Range | 0.41 |
| RSI (14) | 45.95 |
| ADX | 18.12 |
| +DI | 24.02 |
| -DI | 17.43 |
| Chandelier Exit (Long, 3 ATRs) | 6.88 |
| Chandelier Exit (Short, 3 ATRs) | 8.10 |
| Upper Bollinger Bands | 7.86 |
| Lower Bollinger Band | 6.94 |
| Percent B (%b) | 0.36 |
| BandWidth | 12.45 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.05 |
| MACD Histogram | -0.007 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.88 | ||||
| Resistance 3 (R3) | 7.85 | 7.62 | 7.78 | ||
| Resistance 2 (R2) | 7.62 | 7.47 | 7.64 | 7.74 | |
| Resistance 1 (R1) | 7.45 | 7.37 | 7.54 | 7.47 | 7.71 |
| Pivot Point | 7.22 | 7.22 | 7.26 | 7.23 | 7.22 |
| Support 1 (S1) | 7.04 | 7.06 | 7.13 | 7.07 | 6.83 |
| Support 2 (S2) | 6.81 | 6.97 | 6.83 | 6.80 | |
| Support 3 (S3) | 6.64 | 6.81 | 6.76 | ||
| Support 4 (S4) | 6.66 |
